Artivion Inc (AORT) (Q3 2026) Earnings Call Highlights: Stent Graft Momentum and Nexus Launch ...
Artivion Inc (AORT) posted 9% constant currency revenue growth on strong stent graft and ONIX demand, but margin pressure and PerClot headwinds temper the 2027 outlook. Related Stocks: AORT ,